We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Quince Therapeutics Inc | NASDAQ:QNCX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.005 | 0.52% | 0.965 | 305 | 13:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 0.9052 | 0.9929 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | -31.39M | -0.7321 | -1.31 | 41.15M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 13:53:35 | 10 | 0.9929 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 28/9/2023 | 21:53 | DJN | Quince Therapeutics to Advance Study of EryDex as FDA Lifts Application.. |
Quince Therapeutics (QNCX) Share Charts1 Year Quince Therapeutics Chart |
|
1 Month Quince Therapeutics Chart |
Intraday Quince Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
